Fumarase deficiency: a difficult diagnosis and a challenging treatment approach
DOI:
https://doi.org/10.30827/ars.v63i2.22369Keywords:
fumarase deficiency, lactic acidemia, organic aciduria, ketogenic diet, metabolic diseaseAbstract
Introduction: Fumarase deficiency is a rare autosomal metabolic disease that curse with hypotonia, hyperlacticaemia and seizures. Diagnosis based in laboratory test might be done carefully, as most of metabolic diseases present similar symptomatology: hypotony, convulsions, lactic and pyruvic acidemia.
Method: The objective is to analyse the pharmacological and nutritional approach of a neonate who presented symptoms of metabolic congenital disorders.
Results: The patient is a three-month girl with heterozygote mutation in fumarase gene, who presented clinical manifestations of the altered enzyme function. She presented hyperlacticaemia, organic aciduria and alterations of amino acid levels. First diagnosis suspected was pyruvate dehydrogenase deficiency, so nutritional treatment with ketogenic diet was initiated. After medical discharge, she was hospitalized in emergency basis with cardiac arrest and metabolic decompensation. Genetic test revealed a heterozygote mutation in fumarase. Clinical symptomatology could have worsened because of the difficult diagnosis.
Conclusions: Nutritional and pharmacological treatment of fumarase deficiency is considered essential for the patient’s evolution, but further researchers must be carried out to profoundly understand the mechanism underlying metabolic inborn errors. Multidisciplinary teams would manage the disease from the point of view of diverse clinician experts so the correct diagnosis and treatment would be decided with precision.
Downloads
References
Zinn AB, Kerr DS, Hoppel CL. Fumarase deficiency: A new cause of mitochondrial encephalomyopathy. N Engl J Med. 1986;315(8):469–475. doi: 10.1056/NEJM198608213150801.
Ewbank C, Kerrigan JF, Aleck K. Fumarate Hydratase Deficiency. Seattle: Seattle, WA: University of Washington; 2013. [http://www.genereviews.org/] [PMID: 20301679]
Yang M, Soga, T, Pollard P J, Adam J. The emerging role of fumarate as an oncometabolite. Front Oncol. 2012; 2:85. Doi:10.3389/fonc.2012.00085
Stern, H. J. Lactic Acidosis in Paediatrics: Clinical and Laboratory Evaluation, Ann Clin Biochem. 1994;31(5):410–419. Doi:10.1177/000456329403100502.
Ryder B, Moore F, Mitchell A, Thompson S, Christodoulou J, Balasubramaniam S. Fumarase Deficiency: A Safe and Potentially Disease Modifying Effect of High Fat/Low Carbohydrate Diet. JIMD Rep. 2018;40:77–83. Doi:10.1007/8904_2017_65
Kimonis VE, Steller J, Sahai I, et al. Mild fumarase deficiency and trial of a low protein diet. Mol Genet Metab. 2012;107(1–2):241–242. Doi: 10.1016/j.ymgme.2012.04.010.
Smith AC, Robinson AJ. A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle. BMC Syst Biol. 2011;5:102. Doi: 10.1186/1752-0509-5-102.
Schiff M, Bénit P, Jacobs HT, Vockley J, Rustin, P. Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab. 2012;23(12):488-495. Doi:10.1016/j.tem.2012.04.006
Hou E, Li X, Liu Z, Zhang F, Tian, Z. Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acid metabolism. Biomed Chromatogr. 2018;32(4), 1–9. Doi:10.1002/bmc.4133
Bayley JP, Launonen, V, Tomlinson, IP. The FH mutation database: An online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet.2008;9:20. Doi:10.1186/1471-2350-9-20
Ottolenghi C, Hubert L, Allanore Y et al. Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat. 2011;32(9):1046–1052. doi: 10.1002/humu.21534.
Saini AG, Singhi P. Infantile metabolic encephalopathy due to fumarase deficiency. J Child Neurol. 2013;28(4), 535–537. Doi:10.1177/0883073812447286
Loeffen J, Smeets R, Voit T, Hoffmann G, Smeitink J. Fumarase deficiency presenting with periventricular cysts. J Inherit Metab Dis. 2005;28(5):799–800. Doi: 10.1007/s10545-005-0044-7
Peetsold M, Goorden S, Breuning M, et al. Fumarase deficiency: A case with a new pathogenic mutation and a review of the literature. J Child Neurol. 2021;36(4):310-323. doi:10.1177/0883073820962931
Chaturvedi S, Singh AK, Keshari AK, Maity S, Sarkar S, Saha S. Human Metabolic Enzymes Deficiency: A Genetic Mutation Based Approach. Scientifica (Cairo). 2016; 2016:9828672. doi:10.1155/2016/9828672
Cardellach F, Ribes A. Medicina interna y enfermedades raras. Transición niño-adulto. Arbor. 2018;194(789): a460. Doi:10.3989/ arbor.2018.789n3002
Boyer SW, Barclay, LJ, Burrage LC. Inherited Metabolic Disorders. Nutr Clin Pract. 2015;30: 502-510. doi:10.1177/0884533615586201
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Celia Castaño Amores, Pelayo Nieto-Gómez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
